Smith & Nephew plc (ADR) (NYSE:SNN) has risen 3.46% since October 12, 2016 and is uptrending. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.67 average brokerage recommendation. The Manufacturers Life Insurance Company grew its position in Smith & Nephew SNATS by 0.9% in the 2nd quarter. Comerica Bank raised its position in Smith & Nephew plc by 2.0% in the fourth quarter. The company has a 50 day moving average of $36.37 and a 200-day moving average of $34.69. Similar statistics are true for the second largest owner, Arrowstreet Capital, Limited Partnership, which owns 2,986,759 shares of the stock are valued at $107.94 million.
Stock analysts at Canaccord Genuity initiated coverage on shares of Smith & Nephew PLC (ADR) (NYSE:SNN) in a report revealed to investors on 11 October. Wells Fargo & Company MN's holdings in Smith & Nephew plc were worth $13,285,000 as of its most recent filing with the SEC. The company was upgraded on Thursday, December 8 by Morgan Stanley. Smith & Nephew plc has a 52 week low of $26.97 and a 52 week high of $35.30. They now have a United States dollars 33 price target on the stock. Shareholders of record on Friday, March 31st were given a $0.37 dividend. The ex-dividend date was Wednesday, March 29th.
A number of other analysts have also recently weighed in on SNN. The stock has "Equal-Weight" rating by Barclays Capital on Wednesday, August 10.
Canaccord Genuity started coverage on shares of Smith & Nephew SNATS, Inc. Zacks Investment Research cut shares of Smith & Nephew SNATS from a buy rating to a hold rating in a report on Wednesday, October 4th. HSBC initiated the shares of SNN in report on Thursday, January 19 with "Hold" rating. However, Smith & Nephew's prior public difficulties regarding the lofty salary of chief executive Olivier Bohuon, relatively modest earnings progression this decade and margins which lag those of the peer group all mean it is a potential target for an activist.
Cambiar Investors Llc owns $191.14 million in Smith & Nephew plc, which represents roughly 1.15% of the company's market cap and approximately 18.96% of the institutional ownership. The Firm is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
Sources with knowledge of the matter told Bloomberg last night that billionaire Paul Singer's hedge fund Elliott Management had built up a stake in Smith & Nephew, without, however, specifying the size of the stake.
Mali, Paraguay seal knock-out spots
It was all but over for the men in red who were staring at yet another embarrassing defeat and bow out of the tournament with just 1 point.
Mother and young son survive 10 days in Australian bush
The 40-year-old and the boy planned a two-hour walk in Mount Royal National Park in the Hunter region some 240km north of Sydney. The pair only had water with them, and when that ran out they relied on water from natural resources.